- JP-listed companies
- TMS Co., Ltd
- Dividends
TMS Co., Ltd【JP:4891】Dividends
Market cap
¥6.2B
P/E ratio
Timbs Inc. develops anti-inflammatory drugs from black mold compounds, targeting diseases like stroke and inflammatory conditions through partnerships with major pharmaceutical companies.
Latest Dividend per Share Forecast
0.00JPY
If you buy 100 shares of TMS Co., Ltd, the expected annual dividend is 0 JPY.
- Dividend Yield
- -
- Payout Ratio
- -
Dividend Policy
<p>We consider returning profits to shareholders as an important policy. However, we determine dividends while taking into account the need to build up internal reserves for research and development investment. For the time being, we plan to pay no dividend in order to actively pursue pharmaceutical research and development, allocating all internal reserves generated from profits to research and development. When we do pay a dividend from surplus earnings, we plan to do so once per year at the fiscal year-end.</p>
Dividend per Share
Payout Ratio
Dividend Yield
Dividend History (Forecasts, Revisions, Actuals)
| Fiscal Year | Type | Interim | Year-End | Total | Payout Ratio |
| FY2026 | Forecast(2025/04/11) | 0 | 0 | 0 | - |
|---|---|---|---|---|---|
| FY2025 | Actual(2025/04/11) | 0 | 0 | 0 | - |
| Forecast(2024/04/12) | 0 | 0 | 0 | - | |
| FY2024 | Actual(2024/04/12) | 0 | 0 | 0 | - |
| Forecast(2023/04/14) | 0 | 0 | 0 | - | |
| FY2023 | Actual(2023/04/14) | 0 | 0 | 0 | - |
| Forecast(2023/01/13) | 0 | 0 | 0 | - | |
| FY2022 | Actual(2023/01/13) | 0 | 0 | 0 | - |